- Home
- Search Results
Search Results
Filter :
FILTER BY keyword:
FILTER BY author:
- Abdullah Hamad [2]
- Alaa Rahhal [1]
- Bisher Sawaf [1]
- Fadumo Yasin [1]
- Fadwa Al-Ali [1]
- Fatma Ramadan [1]
- Hany Ezzat [1]
- Ibrahim Obeidat [1]
- Iheb Bougmiza [1]
- Khaled Ali [1]
- Khaled Mohamed Mahmoud [1]
- Mhd Baraa Habib [1]
- Mohammed Altermanini [1]
- Nadia Noor [1]
- Rania Ibrahim [1]
- Sahar Ismail [1]
- Sahar Ismail Aly [1]
- Tarek Abdel Latif Ghonimi [1]
- Tarek Abdel latif [1]
- [+] More [-] Less
FILTER BY language:
FILTER BY content type:
FILTER BY publication:
FILTER BY affiliation:
- Community Medicine Department, Hamad Medical Corporation, Doha, Qatar Email: [email protected] ORCID iD: 0000-0002-8073-4375 [1]
- Community Medicine Department, Primary Health Care Corporation, Doha, Qatar [1]
- Hamad Medical Corporation, Doha, Qatar E-mail: [email protected] [1]
- Internal Medicine Department, Hamad Medical Corporation, Doha, Qatar [1]
- Nephrology Division, Department of Medicine, Hamad Medical Corporation, Doha, Qatar [1]
- Pharmacy Department, Hamad Medical Corporation, Doha, Qatar [1]
FILTER BY article type:
FILTER BY access type:
Effects of novel anemia nurse manager program on hemodialysis: a retrospective study from Qatar
Introduction: Anemia management in dialysis is challenging. Keeping hemoglobin levels within a tight range is difficult. A new program (anemia nurse manager [ANM]) was started for better anemia management. This study aimed to compare traditional anemia management with the new ANM model regarding the achievement of better hemoglobin targets (range 10–12 g/dL) avoidance of extreme hemoglobin levels ( < 9 or >13 g/dL) and evaluation of the cost-effectiveness of the new model.
Methods: This retrospective observational study compared traditional anemia management with management involving our new ANM model. Patients on hemodialysis in all ambulatory dialysis clinics in Qatar were included. The study included three phases: phase 1 (observation): June 2015 to August 2015 460 patients; phase 2 (pilot): September 2015 to May 2016 211 patients; and phase 3 (expansion in two phases): June 2016 to February 2017 and October 2017 to June 2018 610 patients. Hemoglobin iron saturation and ferritin were evaluated according to the protocol.
Results: In this study 55% of the patients achieved the target hemoglobin in phase 1 compared with 75% in phase 2 (p = 0.0007). The hemoglobin level within the target range was sustained at 72% ± 5% of patients in phase 3. The achievement rate of the target hemoglobin level increased from 56% (May 2015) to 72% (July 2018) (p < 0.001). The proportion of patients with extreme hemoglobin declined from 10.7% in phase 1 to 6.4% in phase 2 and sustained at 8% afterward. Reducing the doses of erythropoietin stimulating agents owing to the use of the ANM model saved costs by approximately 11%.
Conclusions: The ANM model was able to achieve and maintain hemoglobin levels within the target range and decrease extreme hemoglobin levels. These outcomes improved patient care by avoiding high hemoglobin (increase thrombosis cancer recurrence stroke and death) and low hemoglobin (weakness poor quality of life and need for transfusion) levels. The ANM model was cost effective even after including the salaries of nurses. This model can be considered in other aspects of patient care in dialysis.
Determinants of vaccine adherence among non-dialysis chronic kidney disease patients in Qatar
Introduction: Chronic kidney disease (CKD) is a global health problem. Reduced innate and adaptive immunological responses predispose CKD patients to infections. Despite the clinical and epidemiological importance of CKD and the great value of vaccination as a prophylactic measure the utilization of recommended vaccines in Qatar has not yet been evaluated.
Methods: We conducted a cross-sectional study to estimate the level of influenza pneumococcal and hepatitis B vaccination and the predictors of adherence to these recommended vaccines among non-dialysis CKD patients receiving renal ambulatory care in Qatar from 1 September 2020 to 30 April 2021. Complete vaccination was defined as receiving the three vaccines and partial vaccination was defined as receiving one or two vaccines. The full and partial vaccination predictors were assessed using multivariate logistic regression and reported as odds ratio (OR) with p<0.05 indicating statistical significance.
Results: 416 non-dialysis CKD patients were included in our analysis. 73% were males; the mean age was 56 ± 15 years. More than 50% of the patients were from the Middle East followed by 36% from Asia. Most patients had concurrent hypertension concurrent diabetes mellitus and were stage V CKD. Only 12% of the patients were fully vaccinated while 73% received partial vaccination. The predictors of vaccination included age gender Asian origin employment living conditions concurrent medical conditions CKD stage allergy to medications and use of injectable medications. Only stage V CKD positively predicted adherence to full and partial vaccinations in non-dialysis CKD patients.
Conclusion: There is very low adherence to the recommended vaccines in CKD patients with a prevalence of complete vaccination of 12% only. Increased public awareness about the importance of vaccination in CKD may improve the adherence rates among these patients in Qatar.